Geoffrey C. Dunbar
2009
In 2009, Geoffrey C. Dunbar earned a total compensation of $569.2K as Senior Vice President, Clinical Development and Regulatory Affairs and Chief Medical Officer at Catalyst Biosciences, a 59% increase compared to previous year.
Compensation breakdown
Bonus | $83,708 |
---|---|
Non-Equity Incentive Plan | $89,821 |
Option Awards | $88,835 |
Salary | $292,102 |
Other | $14,700 |
Total | $569,166 |
Dunbar received $292.1K in salary, accounting for 51% of the total pay in 2009.
Dunbar also received $83.7K in bonus, $89.8K in non-equity incentive plan, $88.8K in option awards and $14.7K in other compensation.
Rankings
In 2009, Geoffrey C. Dunbar's compensation ranked 6,395th out of 9,885 executives tracked by ExecPay. In other words, Dunbar earned more than 35.3% of executives.
Classification | Ranking | Percentile |
---|---|---|
All | 6,395 | 35th |
Manufacturing | 2,331 | 37th |
Chemicals And Allied Products | 506 | 42nd |
Drugs | 341 | 47th |
Pharmaceutical Preparations | 242 | 46th |
Dunbar's colleagues
We found four more compensation records of executives who worked with Geoffrey C. Dunbar at Catalyst Biosciences in 2009.
2009
J deBethizy
Catalyst Biosciences
Chief Executive Officer
2009
Jeffrey Brennan
Catalyst Biosciences
Senior Vice President, Business and Commercial Development and Chief Business Officer
2009
Alan Musso
Catalyst Biosciences
Chief Financial Officer
2009
Peter Zorn
Catalyst Biosciences